Serum Olink Targeted Proteomics Identifies IL-17A as a Prospective Inflammatory Marker for the Prediction and Diagnosis of Kawasaki Disease
Xiaoxuan Tu,
No information about this author
Xueqi Chen,
No information about this author
Liyan Xu
No information about this author
et al.
Journal of Inflammation Research,
Journal Year:
2025,
Volume and Issue:
Volume 18, P. 3093 - 3103
Published: March 1, 2025
Kawasaki
disease
(KD)
is
an
acute
febrile
vasculitis
and
the
leading
cause
of
acquired
heart
in
children.
However,
early
diagnosis
KD
remains
challenging,
its
pathogenic
mechanisms
are
yet
to
be
fully
elucidated.
This
study
utilized
Olink
Targeted
Proteomics
analyze
serum
protein
profiles
identify
potential
diagnostic
biomarkers
for
patients
with
KD.
Based
on
children
final
diagnosis,
they
were
categorized
into
either
group
or
control
(FC)
group.
Serum
samples
from
each
randomly
selected
analyzed
using
Target
96
Inflammation
panel.
A
retrospective
analysis
clinical
data
was
also
conducted.
By
integrating
results
data,
receiver
operating
characteristic
(ROC)
curve
performed
determine
critical
thresholds
identified
biomarkers.
25
differentially
expressed
proteins,
18
upregulated
7
downregulated
proteins
Using
LASSO
regression
analysis,
we
5
biomarkers,
IL-17A,
CCL23,
SCF,
TWEAK,
NT-3,
that
could
used
distinguish
FC.
Among
these,
IL-17A
exhibited
greatest
fold
change.
Additionally,
a
subset
participants
underwent
cytokine
testing
within
first
days
fever
onset
during
hospitalization.
Our
this
found
IL-17
levels
significantly
elevated
subsequently
diagnosed
suggest
inflammation-associated
strongly
linked
family,
especially
showed
best
correlation,
providing
clinicians
new
biomarker
Language: Английский
Update on Diagnosis and Management of Kawasaki Disease: A Scientific Statement From the American Heart Association
Journal of Cardiothoracic and Vascular Anesthesia,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 1, 2025
Language: Английский
Gut microbiota, inflammatory cytokines, and Kawasaki disease: a Mendelian randomization study and mediation analysis
Ji‐Gan Wang,
No information about this author
Hui‐Hong Dou,
No information about this author
Qiujuan Liang
No information about this author
et al.
Pediatric Research,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Feb. 10, 2025
Language: Английский
Interplay of gut microbiota in Kawasaki disease: role of gut microbiota and potential treatment strategies
Qing Yang,
No information about this author
Yaqing Kang,
No information about this author
Wei Tang
No information about this author
et al.
Future Microbiology,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 13
Published: Feb. 27, 2025
Kawasaki
disease
(KD)
is
an
acute
systemic
immune
vasculitis
with
predominant
involvement
of
the
medium
and
small
arteries.
It
mostly
affects
pediatric
patients,
representing
most
common
form
in
children
less
than
5
years
old.
Numerous
diseases,
especially
those
related
to
system,
have
established
links
intestinal
flora.
Recent
studies
investigated
flora
changes
throughout
management
KD.
There
was
gut
microbiota
dysbiosis
KD
at
phase,
particularly
downregulation
short-chain
fat
acids-producing
over-proliferation
opportunistic
pathogens.
The
relationship
between
response
therapies
individuals
specific
remains
uncertain.
Targeted
microbial
supplements
dietary
regulation
may
serve
as
potential
measures
alleviate
complications
thus
improve
prognosis.
This
review
provides
overview
current
understanding
interplay
Furthermore,
it
discusses
possibility
altering
reinstate
a
healthy
condition.
Language: Английский
Unveiling the anti-inflammatory mechanism of exogenous hydrogen sulfide in Kawasaki disease based on network pharmacology and experimental validation
Ling Yu,
No information about this author
Qianwen Luo,
No information about this author
Xiaohui Rao
No information about this author
et al.
Scientific Reports,
Journal Year:
2025,
Volume and Issue:
15(1)
Published: March 3, 2025
Kawasaki
disease
(KD)
is
a
severe
pediatric
vasculitis
leading
to
coronary
artery
complications.
Hydrogen
sulfide
(H2S),
recognized
endogenous
gasotransmitter
with
anti-inflammatory
properties,
offers
potential
as
novel
treatment
for
KD
through
its
cardiovascular
benefits.
However,
the
specific
effects
and
underlying
mechanisms
remain
unclear.
The
objective
of
present
study
investigate
therapeutic
exogenous
H2S
in
using
network
pharmacology
experimental
validation.
By
online
database
searches,
total
405
pharmacological
targets
H2S,
826
KD-related
targets,
107
were
identified.
Through
PPI
analysis
Cytoscape
screening,
9
hub
genes
filtered,
namely
TNF,
IL6,
JUN,
AKT1,
IL1B,
TP53,
NFKB1,
MAPK1,
RELA.
KEGG
pathway
enrichment
indicated
that
TLR4/MyD88/NF-κB
signaling
may
play
crucial
role
on
KD.
Additionally,
vivo
experiments
confirmed
sodium
hydrosulfide
(NaHS),
an
donor,
markedly
improved
body
weight,
reduced
inflammatory
pathology
arteries,
downregulated
levels
cytokines
TNF-α,
IL-1β,
IL-6.
Furthermore,
WB
NaHS
inhibited
expression
TLR4,
MyD88,
NF-κB,
p-NF-κB.
In
brief,
it
first
reveal
attenuates
response
via
pathway,
highlighting
approach
These
findings
lay
foundation
further
development
H2S-based
therapies
management.
Language: Английский
Prenatal and Postnatal Ambient Air Pollution and Kawasaki Disease
JACC Advances,
Journal Year:
2025,
Volume and Issue:
4(4), P. 101651 - 101651
Published: March 14, 2025
Accumulating
evidence
indicates
associations
between
ambient
air
pollution
and
Kawasaki
disease
(KD),
but
the
results
remain
inconsistent.
This
systematic
review
meta-analysis
aimed
to
comprehensively
summarize
current
on
effects
of
pollutants
KD.
The
PubMed,
Web
Science,
Embase,
Scopus
databases
were
searched
up
January
18,
2025
for
studies
investigating
A
fixed-
or
random-effects
model
was
used
calculate
pooled
ORs
with
95%
CIs
an
increase
in
pollutant
concentration
10
μg/m3.
risk
bias
assessed
using
Risk
Bias
In
Nonrandomized
Studies
Exposures
tool,
quality
by
Grading
Recommendations,
Assessment,
Development,
Evaluations
framework.
protocol
registered
PROSPERO
(CRD42024545321).
Thirteen
124,857
participants
included.
Seven
at
high
bias.
revealed
increased
KD
after
short-term
postnatal
exposure
PM2.5
(OR:
1.011;
CI:
1.003-1.019;
I2
=
0%;
high-quality
evidence)
PM10
1.004;
1.000-1.008;
38%;
evidence),
as
well
long-term
1.415;
1.179-1.697;
41%;
evidence).
Prenatal
carbon
monoxide,
nitric
oxide,
nitrogen
oxides,
sulfur
dioxide;
oxide;
monoxide
oxides
also
associated
occurrence.
Both
prenatal
several
are
Language: Английский